A novel treatment strategy targeting cellular pathways with natural products to alleviate sarcopenia
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867021676699451392 |
|---|---|
| author | Da Hee Lee Hye Jin Lee Gabsik Yang Dae Yong Kim Jong Uk Kim Tae Han Yook Jun Ho Lee Hong Jun Kim |
| author_facet | Da Hee Lee Hye Jin Lee Gabsik Yang Dae Yong Kim Jong Uk Kim Tae Han Yook Jun Ho Lee Hong Jun Kim Da Hee Lee Hye Jin Lee Gabsik Yang Dae Yong Kim Jong Uk Kim Tae Han Yook Jun Ho Lee Hong Jun Kim |
| collection | Wiley Open Access |
| contents | A novel treatment strategy targeting cellular pathways with natural products to alleviate sarcopenia Da Hee Lee Hye Jin Lee Gabsik Yang Dae Yong Kim Jong Uk Kim Tae Han Yook Jun Ho Lee Hong Jun Kim Phytotherapy Research AbstractSarcopenia is a condition marked by a significant reduction in muscle mass and strength, primarily due to the aging process, which critically impacts muscle protein dynamics, metabolic functions, and overall physical functionality. This condition leads to increased body fat and reduced daily activity, contributing to severe health issues and a lower quality of life among the elderly. Recognized in the ICD‐10‐CM only in 2016, sarcopenia lacks definitive treatment options despite its growing prevalence and substantial social and economic implications. Given the aging global population, addressing sarcopenia has become increasingly relevant and necessary. The primary causes include aging, cachexia, diabetes, and nutritional deficiencies, leading to imbalances in protein synthesis and degradation, mitochondrial dysfunction, and hormonal changes. Exercise remains the most effective intervention, but it is often impractical for individuals with limited mobility, and pharmacological options such as anabolic steroids and myostatin inhibitors are not FDA‐approved and are still under investigation. This review is crucial as it examines the potential of natural products as a novel treatment strategy for sarcopenia, targeting multiple mechanisms involved in its pathogenesis. By exploring natural products' multi‐targeted effects, this study aims to provide innovative and practical solutions for sarcopenia management. Therefore, this review indicates significant improvements in muscle mass and function with the use of specific natural compounds, suggesting promising alternatives for those unable to engage in regular physical activity. 10.1002/ptr.8301 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1002/ptr.8301 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_ptr_8301 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | A novel treatment strategy targeting cellular pathways with natural products to alleviate sarcopenia Da Hee Lee Hye Jin Lee Gabsik Yang Dae Yong Kim Jong Uk Kim Tae Han Yook Jun Ho Lee Hong Jun Kim Phytotherapy Research A novel treatment strategy targeting cellular pathways with natural products to alleviate sarcopenia Da Hee Lee Hye Jin Lee Gabsik Yang Dae Yong Kim Jong Uk Kim Tae Han Yook Jun Ho Lee Hong Jun Kim Phytotherapy Research AbstractSarcopenia is a condition marked by a significant reduction in muscle mass and strength, primarily due to the aging process, which critically impacts muscle protein dynamics, metabolic functions, and overall physical functionality. This condition leads to increased body fat and reduced daily activity, contributing to severe health issues and a lower quality of life among the elderly. Recognized in the ICD‐10‐CM only in 2016, sarcopenia lacks definitive treatment options despite its growing prevalence and substantial social and economic implications. Given the aging global population, addressing sarcopenia has become increasingly relevant and necessary. The primary causes include aging, cachexia, diabetes, and nutritional deficiencies, leading to imbalances in protein synthesis and degradation, mitochondrial dysfunction, and hormonal changes. Exercise remains the most effective intervention, but it is often impractical for individuals with limited mobility, and pharmacological options such as anabolic steroids and myostatin inhibitors are not FDA‐approved and are still under investigation. This review is crucial as it examines the potential of natural products as a novel treatment strategy for sarcopenia, targeting multiple mechanisms involved in its pathogenesis. By exploring natural products' multi‐targeted effects, this study aims to provide innovative and practical solutions for sarcopenia management. Therefore, this review indicates significant improvements in muscle mass and function with the use of specific natural compounds, suggesting promising alternatives for those unable to engage in regular physical activity. 10.1002/ptr.8301 http://creativecommons.org/licenses/by/4.0/ |
| title | A novel treatment strategy targeting cellular pathways with natural products to alleviate sarcopenia |
| topic | Phytotherapy Research |
| url | https://onlinelibrary.wiley.com/doi/10.1002/ptr.8301 |